BSECompany Update3d ago
GlaxoSmithKline Pharmaceuticals Ltd
As per attachment
GlaxoSmithKline Pharmaceuticals Ltd has uploaded the recording of its analyst/institutional investor meetings as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
BSEResultResults3d ago
India Home Loan Ltd
Please find enclosed Unaudited Financial results for the quarter and half year ended September 30, 2026
India Home Loan Ltd has announced unaudited financial results for the quarter and half year ended September 30, 2026, along with the appointment of new directors and key managerial personnel.
BSECompany UpdateRegulatory3d ago
Entero Healthcare Solutions Ltd
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Entero Healthcare Solutions Ltd has disclosed a default in payment of outstanding dues by its subsidiary Vasavi Medicare Solutions Private Ltd to its customer S M Pharma, amounting to INR 11.87 crore. Vasavi has made a provision for the entire amount and is initiating legal proceedings for recovery.
BSECompany UpdateMgmt Change3d ago
JSW Dulux Limited
JSW Dulux Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
JSW Dulux Limited has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change3d ago
JSW Dulux Limited
JSW Dulux Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
JSW Dulux Limited has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change3d ago
JSW Dulux Limited
JSW Dulux Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
JSW Dulux Limited has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change3d ago
JSW Dulux Limited
JSW Dulux Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
JSW Dulux Limited has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change3d ago
JSW Dulux Limited
JSW Dulux Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
JSW Dulux Limited has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change3d ago
JSW Dulux Limited
JSW Dulux Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
JSW Dulux Limited has informed BSE about the appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change3d ago
JSW Dulux Limited
JSW Dulux Limited has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
JSW Dulux Limited has informed BSE about the appointment of a Non-Executive Independent Director.
BSEResultResults3d ago
Filtron Engineers Ltd
Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026
Filtron Engineers Ltd has announced its standalone and consolidated financial results for the quarter and half year ended September 30, 2026, showing a profit of ₹22,871.80 lakhs and ₹22,972.51 lakhs respectively. The company has also approved the execution of a rent agreement for its registered office.
BSEBoard MeetingResults3d ago
Sunil Agro Foods Ltd-$
Sunil Agro Foods Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve the Un-Audited Financial results for the second quarter and half year ended September 30, 2026.
Sunil Agro Foods Ltd has scheduled a Board Meeting on 12/11/2026 to consider and approve the Un-Audited Financial results for the second quarter and half year ended September 30, 2026.
BSECompany Update▲ PositiveResults3d ago
Krishival Foods Ltd
Media Release
Krishival Foods Ltd reported strong Q2 FY27 performance with consolidated EBITDA growing 64% YoY and EBITDA margin expanding to 16%. Revenue from operations increased 28% YoY to ₹85.66 crore and H1 revenue grew 50% YoY to ₹174.62 crore.
BSECompany UpdateMgmt Change3d ago
AUROBINDO PHARMA LIMITED
AUROBINDO PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Aurobindo Pharma Limited has informed the BSE about the re-appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change3d ago
AUROBINDO PHARMA LIMITED
AUROBINDO PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Aurobindo Pharma Limited has informed BSE about the re-appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change3d ago
AUROBINDO PHARMA LIMITED
AUROBINDO PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Aurobindo Pharma Limited has informed the BSE about the re-appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change3d ago
AUROBINDO PHARMA LIMITED
AUROBINDO PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Aurobindo Pharma Limited has informed the BSE about the re-appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change3d ago
AUROBINDO PHARMA LIMITED
AUROBINDO PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Aurobindo Pharma Limited has informed BSE about the re-appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change3d ago
AUROBINDO PHARMA LIMITED
AUROBINDO PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Aurobindo Pharma has informed about the re-appointment of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change3d ago
AUROBINDO PHARMA LIMITED
AUROBINDO PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Aurobindo Pharma Limited has informed BSE about the re-appointment of a Non-Executive Independent Director.